94 related articles for article (PubMed ID: 11220653)
1. Susceptibility markers in colorectal cancer.
Burn J; Chapman PD; Bishop DT; Smalley S; Mickleburgh I; West S; Mathers JC
IARC Sci Publ; 2001; 154():131-47. PubMed ID: 11220653
[TBL] [Abstract][Full Text] [Related]
2. Can we identify the high-risk patients to be screened? A genetic approach.
Gammon A; Kohlmann W; Burt R
Digestion; 2007; 76(1):7-19. PubMed ID: 17947814
[TBL] [Abstract][Full Text] [Related]
3. [Recent notions on intestinal cancerogenesis, their implications in genetic risk screening and preventive action of non-steroid anti-inflammatory agents].
Couturier D
Bull Acad Natl Med; 2002; 186(2):421-43; discussion 443-5. PubMed ID: 12145848
[TBL] [Abstract][Full Text] [Related]
4. Genetic predisposition to colorectal cancer.
de la Chapelle A
Nat Rev Cancer; 2004 Oct; 4(10):769-80. PubMed ID: 15510158
[TBL] [Abstract][Full Text] [Related]
5. Hereditary colorectal cancer syndromes.
Strate LL; Syngal S
Cancer Causes Control; 2005 Apr; 16(3):201-13. PubMed ID: 15947872
[TBL] [Abstract][Full Text] [Related]
6. Simple and complex genetics of colorectal cancer susceptibility.
Baglioni S; Genuardi M
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):35-43. PubMed ID: 15264271
[TBL] [Abstract][Full Text] [Related]
7. Colorectal cancer as a complex disease: defining at-risk subjects in the general population - a preventive strategy.
Lindblom A; Zhou XL; Liu T; Liljegren A; Skoglund J; Djureinovic T;
Expert Rev Anticancer Ther; 2004 Jun; 4(3):377-85. PubMed ID: 15161437
[TBL] [Abstract][Full Text] [Related]
8. Low frequency of AXIN2 mutations and high frequency of MUTYH mutations in patients with multiple polyposis.
Lejeune S; Guillemot F; Triboulet JP; Cattan S; Mouton C; ; Porchet N; Manouvrier S; Buisine MP
Hum Mutat; 2006 Oct; 27(10):1064. PubMed ID: 16941501
[TBL] [Abstract][Full Text] [Related]
9. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
10. Scoping the family history: assessment of Lynch syndrome (hereditary nonpolyposis colorectal cancer) in primary care settings--a primer for nurse practitioners.
Maradiegue A; Jasperson K; Edwards QT; Lowstuter K; Weitzel J
J Am Acad Nurse Pract; 2008 Feb; 20(2):76-84. PubMed ID: 18271762
[TBL] [Abstract][Full Text] [Related]
11. Inherited predisposition to cancer: a historical overview.
Lynch HT; Shaw TG; Lynch JF
Am J Med Genet C Semin Med Genet; 2004 Aug; 129C(1):5-22. PubMed ID: 15264268
[TBL] [Abstract][Full Text] [Related]
12. Prospective results of surveillance colonoscopy in dominant familial colorectal cancer with and without Lynch syndrome.
Dove-Edwin I; de Jong AE; Adams J; Mesher D; Lipton L; Sasieni P; Vasen HF; Thomas HJ
Gastroenterology; 2006 Jun; 130(7):1995-2000. PubMed ID: 16762622
[TBL] [Abstract][Full Text] [Related]
13. Who should be sent for genetic testing in hereditary colorectal cancer syndromes?
Lynch HT; Boland CR; Rodriguez-Bigas MA; Amos C; Lynch JF; Lynch PM
J Clin Oncol; 2007 Aug; 25(23):3534-42. PubMed ID: 17687158
[TBL] [Abstract][Full Text] [Related]
14. The genetics of hereditary colon cancer.
Rustgi AK
Genes Dev; 2007 Oct; 21(20):2525-38. PubMed ID: 17938238
[TBL] [Abstract][Full Text] [Related]
15. Prediction of Lynch syndrome in consecutive patients with colorectal cancer.
Green RC; Parfrey PS; Woods MO; Younghusband HB
J Natl Cancer Inst; 2009 Mar; 101(5):331-40. PubMed ID: 19244167
[TBL] [Abstract][Full Text] [Related]
16. Molecular genetic alterations and clinical features in early-onset colorectal carcinomas and their role for the recognition of hereditary cancer syndromes.
Losi L; Di Gregorio C; Pedroni M; Ponti G; Roncucci L; Scarselli A; Genuardi M; Baglioni S; Marino M; Rossi G; Benatti P; Maffei S; Menigatti M; Roncari B; Ponz de Leon M
Am J Gastroenterol; 2005 Oct; 100(10):2280-7. PubMed ID: 16181381
[TBL] [Abstract][Full Text] [Related]
17. A social network analysis of communication about hereditary nonpolyposis colorectal cancer genetic testing and family functioning.
Koehly LM; Peterson SK; Watts BG; Kempf KK; Vernon SW; Gritz ER
Cancer Epidemiol Biomarkers Prev; 2003 Apr; 12(4):304-13. PubMed ID: 12692104
[TBL] [Abstract][Full Text] [Related]
18. How the I1307K adenomatous polyposis coli gene variant contributes in the assessment of risk of colorectal cancer, but not stomach cancer, in a Turkish population.
Dundar M; Caglayan AO; Saatci C; Karaca H; Baskol M; Tahiri S; Ozkul Y
Cancer Genet Cytogenet; 2007 Sep; 177(2):95-7. PubMed ID: 17854661
[TBL] [Abstract][Full Text] [Related]
19. The I1307K adenomatous polyposis coli gene variant does not contribute in the assessment of the risk for colorectal cancer in Ashkenazi Jews.
Strul H; Barenboim E; Leshno M; Gartner M; Kariv R; Aljadeff E; Aljadeff Y; Kazanov D; Strier L; Keidar A; Knaani Y; Degani Y; Alon-Baron L; Sobol-Dvory H; Halpern Z; Arber N
Cancer Epidemiol Biomarkers Prev; 2003 Oct; 12(10):1012-5. PubMed ID: 14578136
[TBL] [Abstract][Full Text] [Related]
20. Inherited genetic susceptibility to breast cancer.
Chang-Claude J
IARC Sci Publ; 2001; 154():177-90. PubMed ID: 11220657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
